# Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission

> **NCT03841942** · NA · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 64 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **OTHER:** clinically-based spacing strategy
- **OTHER:** Trough level-based strategy

## Key facts

- **NCT ID:** NCT03841942
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-26
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** difficulty of inclusion
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03841942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03841942, "Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03841942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*